Over the past five years, the company has achieved an impressive compound annual growth rate (CAGR) of 33.9% in terms of its profit.
Company has a good return on capital employed (ROCE) of 61.5 %.
Stock has negligible debt to equity of 0.09. /list
Currently price is at somewhere between support and resistance level of the...
*Entry can be initiated if it is closing above 650 level for the day, As it is very close to give multipattern Breakout.
*Stock has given good profit growth of 23.0% CAGR over last 5 years.
*company has increased its net profit from 33cr to 815cr YOY basic in just 10 years.
IDFC First Q1 Result.
Impressive performance across the board! Deposits up 44% YoY, Advances up 25% YoY, Profits up 61% YoY. Net NPA down to 0.7% (Which is very good indication). ROA at 1.24% vs 0.97% YoY. QoQ net income down -731 Cr. vs 816 Cr. in Q4FY23, but excluding a one-off income of 180-200 cr. from the last quarter, results are still better on a QoQ...
Abbott India Ltd is one of the market leader and multinational pharmaceutical company in India with a global presence in over 160 countries. It has a legacy of more than 130 years in the industry.
In FY22, injectables contributed around 40% of the revenues, followed by tablets at 39%, liquids at approximately 16%, capsules...
This is my second analysis of BTC in upcoming days or weeks.
I have seen a lot of people saying BTC will go back to 20k, 25k and even 10k too. They are saying because BTC crashed back in 2016-17. That time, only a few people were into cryptocurrencies.
We should be bullish at this moment but the current circumstances won't let the bull run happen.